The 2024 forecast indicates a gradual decline in ischaemic heart disease mortality among Canadian males, decreasing from 18.22 thousand in 2024 to 17.71 thousand by 2028. This represents a continuous downward trend, with a year-on-year percentage variation revealing a decrease. Between 2026 and 2027 and between 2027 and 2028, the rate decreases steadily by approximately 0.72% each year. The Compound Annual Growth Rate (CAGR) for this period highlights a consistent average yearly decline.
Looking ahead, trends worth monitoring include advances in healthcare technology, lifestyle modifications across the population, and public health initiatives targeting cardiovascular risk factors. These could further influence ischaemic heart disease mortality rates.
